ChemoMetec A/S (LON:0DZ0)
London flag London · Delayed Price · Currency is GBP · Price in DKK
550.23
+1.73 (0.32%)
At close: Jul 9, 2025

ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of GBP 1.11 billion. The enterprise value is 1.08 billion.

Market Cap 1.11B
Enterprise Value 1.08B

Important Dates

The next estimated earnings date is Thursday, September 11, 2025.

Earnings Date Sep 11, 2025
Ex-Dividend Date Oct 11, 2024

Share Statistics

Current Share Class 17.40M
Shares Outstanding n/a
Shares Change (YoY) -0.13%
Shares Change (QoQ) +0.09%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 17.34M

Valuation Ratios

The trailing PE ratio is 59.31 and the forward PE ratio is 44.10.

PE Ratio 59.31
Forward PE 44.10
PS Ratio 21.82
PB Ratio 16.77
P/TBV Ratio 21.58
P/FCF Ratio 65.90
P/OCF Ratio 56.91
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.62, with an EV/FCF ratio of 64.14.

EV / Earnings 57.73
EV / Sales 20.40
EV / EBITDA 42.62
EV / EBIT 44.57
EV / FCF 64.14

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.01.

Current Ratio 4.00
Quick Ratio 2.88
Debt / Equity 0.01
Debt / EBITDA 0.04
Debt / FCF 0.05
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 30.83% and return on invested capital (ROIC) is 23.68%.

Return on Equity (ROE) 30.83%
Return on Assets (ROA) 19.86%
Return on Invested Capital (ROIC) 23.68%
Return on Capital Employed (ROCE) 34.62%
Revenue Per Employee 276,943
Profits Per Employee 101,896
Employee Count 174
Asset Turnover 0.69
Inventory Turnover 0.33

Taxes

In the past 12 months, ChemoMetec has paid 5.69 million in taxes.

Income Tax 5.69M
Effective Tax Rate 23.29%

Stock Price Statistics

The stock price has increased by +52.00% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +52.00%
50-Day Moving Average 518.18
200-Day Moving Average 492.97
Relative Strength Index (RSI) 54.12
Average Volume (20 Days) 570

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of GBP 50.96 million and earned 18.75 million in profits. Earnings per share was 1.08.

Revenue 50.96M
Gross Profit 46.41M
Operating Income 23.32M
Pretax Income 24.44M
Net Income 18.75M
EBITDA 24.39M
EBIT 23.32M
Earnings Per Share (EPS) 1.08
Full Income Statement

Balance Sheet

The company has 29.36 million in cash and 862,368 in debt, giving a net cash position of 28.49 million.

Cash & Cash Equivalents 29.36M
Total Debt 862,368
Net Cash 28.49M
Net Cash Per Share n/a
Equity (Book Value) 66.31M
Book Value Per Share 3.81
Working Capital 40.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.54 million and capital expenditures -2.67 million, giving a free cash flow of 16.87 million.

Operating Cash Flow 19.54M
Capital Expenditures -2.67M
Free Cash Flow 16.87M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 91.07%, with operating and profit margins of 45.77% and 36.79%.

Gross Margin 91.07%
Operating Margin 45.77%
Pretax Margin 47.96%
Profit Margin 36.79%
EBITDA Margin 47.87%
EBIT Margin 45.77%
FCF Margin 33.11%

Dividends & Yields

This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.08%.

Dividend Per Share 0.45
Dividend Yield 0.08%
Dividend Growth (YoY) -35.48%
Years of Dividend Growth n/a
Payout Ratio 41.16%
Buyback Yield 0.13%
Shareholder Yield 0.21%
Earnings Yield 1.69%
FCF Yield 1.52%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ChemoMetec has an Altman Z-Score of 34.57 and a Piotroski F-Score of 4.

Altman Z-Score 34.57
Piotroski F-Score 4